Ascorbic acid and carbonyl iron and Ibritumomab Intravenous
Determining the interaction of Ascorbic acid and carbonyl iron and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ascorbic acid / carbonyl iron
Brand name: Fe C, Icar-C, Vitron-C
Synonyms: n.a.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ascorbic acid and carbonyl iron-Ibritumomab Tiuxetan
- Ascorbic acid and carbonyl iron-Ibrutinib
- Ascorbic acid and carbonyl iron-Ibrutinib Capsules
- Ascorbic acid and carbonyl iron-Ibrutinib Tablets
- Ascorbic acid and carbonyl iron-Ibu
- Ascorbic acid and carbonyl iron-IBU Tablets
- Ibritumomab Intravenous-Ascorbic Acid Injection
- Ibritumomab Intravenous-Ascorbic acid Intravenous
- Ibritumomab Intravenous-Ascorbic Acid Quick Melts
- Ibritumomab Intravenous-Ascriptin
- Ibritumomab Intravenous-Asenapine
- Ibritumomab Intravenous-Asenapine Maleate